Clinical Scorecard: The Role of Transfer RNA Expression, Modifications, and Small RNA Derivatives in Cancer Mechanisms and Therapeutic Implications
At a Glance
Category
Detail
Condition
Cancer
Key Mechanisms
Dysregulation of tRNA expression and modifications, activity of tRNA-derived small RNAs, and aminoacyl-tRNA synthetases influence tumor proliferation, metastasis, stress responses, and therapy resistance.
Target Population
Patients with various types of cancer
Care Setting
Oncology
Key Highlights
tRNA modifications are pivotal in maintaining cellular homeostasis and are linked to cancer development.
Altered tRNA expression patterns in cancer cells can lead to aberrant protein synthesis.
tRNA-derived small RNAs (tsRNAs) are emerging as important regulators in cancer biology.
tRNA-modifying enzymes may serve as potential therapeutic targets in oncology.
Understanding tRNA mechanisms can lead to novel therapeutic strategies in cancer treatment.
Guideline-Based Recommendations
Diagnosis
Assess dysregulated tRNA levels and modifications as potential biomarkers for cancer.
Management
Explore targeting tRNA pathways for therapeutic interventions in cancer.
Monitoring & Follow-up
Monitor expression levels of tRNA and tsRNAs to evaluate cancer progression and therapy response.
Risks
Dysregulation of tRNA pathways may contribute to tumorigenesis and therapy resistance.
Patient & Prescribing Data
Patients diagnosed with cancer exhibiting altered tRNA expression and modifications.
Targeting tRNA-related mechanisms may enhance the efficacy of existing cancer therapies.
Clinical Best Practices
Incorporate assessment of tRNA modifications in cancer diagnostics.
Consider tsRNAs as potential biomarkers for cancer prognosis.
Investigate tRNA-modifying enzymes as therapeutic targets.
